Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Hashemi Goradel

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Advanced Pharmaceutical Bulletin|October 28, 2015
Methods of Liver Stem Cell Therapy in Rodents as Models of Human Liver Regeneration in Hepatic FailureNasser Hashemi Goradel, Masoud Darabi, Karim Shamsasenjan, et al.
Pharmacology & Therapeutics|June 2, 2020
Strategies for enhancing intratumoral spread of oncolytic adenovirusesNasser Hashemi Goradel, Babak Negahdari, Sajjad Ghorghanlu, et al.
Journal of Cellular Physiology|October 21, 2018
Cyclooxygenase-2 in cancer: A reviewNasser Hashemi Goradel, Masoud Najafi, Eniseh Salehi, et al.
International Immunopharmacology|February 25, 2023
Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigenNasser Hashemi Goradel, Mahnaz Nemati, Azam Bakhshandeh, et al.
Iranian Journal of Allergy, Asthma, and Immunology|July 23, 2025
The Antitumor Effect of a Non-transforming E7 Protein Combined with a TLR7 AgonistMaryam Mashhadi Abolghasem Shirazi, Seyed Mehdi Sadat, Nasser Hashemi Goradel, et al.
Journal of Cellular Physiology|September 22, 2018
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatmentBagher Farhood, Nasser Hashemi Goradel, Keywan Mortezaee, et al.
IET Nanobiotechnology|August 7, 2020
Overcoming the blood-brain barrier in neurodegenerative disorders and brain tumoursZahra Ebrahimi, Sam Talaei, Shahin Aghamiri, et al.
Current Problems in Cancer|August 24, 2020
Oncolytic virotherapy: Challenges and solutionsNasser Hashemi Goradel, Alexander T Baker, Arash Arashkia, et al.
Bioimpacts : BI|June 29, 2026
Designing a novel therapeutic candidate vaccine for HPV16 using immunoinformatics approach: Targeting E6 and E7 epitopes with TLR4 agonist integrationZahra Samadi Moghaddam, Maryam Mashhadi Abolghasem Shirazi, Rosa Jahangiri, et al.
Future Oncology (London, England)|November 25, 2021
Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic virusesNasser Hashemi Goradel, Arezoo Alizadeh, Shahnaz Hosseinzadeh, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Advanced Pharmaceutical Bulletin|October 28, 2015
Methods of Liver Stem Cell Therapy in Rodents as Models of Human Liver Regeneration in Hepatic FailureNasser Hashemi Goradel, Masoud Darabi, Karim Shamsasenjan, et al.
Pharmacology & Therapeutics|June 2, 2020
Strategies for enhancing intratumoral spread of oncolytic adenovirusesNasser Hashemi Goradel, Babak Negahdari, Sajjad Ghorghanlu, et al.
Journal of Cellular Physiology|October 21, 2018
Cyclooxygenase-2 in cancer: A reviewNasser Hashemi Goradel, Masoud Najafi, Eniseh Salehi, et al.
International Immunopharmacology|February 25, 2023
Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigenNasser Hashemi Goradel, Mahnaz Nemati, Azam Bakhshandeh, et al.
Iranian Journal of Allergy, Asthma, and Immunology|July 23, 2025
The Antitumor Effect of a Non-transforming E7 Protein Combined with a TLR7 AgonistMaryam Mashhadi Abolghasem Shirazi, Seyed Mehdi Sadat, Nasser Hashemi Goradel, et al.
Journal of Cellular Physiology|September 22, 2018
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatmentBagher Farhood, Nasser Hashemi Goradel, Keywan Mortezaee, et al.
IET Nanobiotechnology|August 7, 2020
Overcoming the blood-brain barrier in neurodegenerative disorders and brain tumoursZahra Ebrahimi, Sam Talaei, Shahin Aghamiri, et al.
Current Problems in Cancer|August 24, 2020
Oncolytic virotherapy: Challenges and solutionsNasser Hashemi Goradel, Alexander T Baker, Arash Arashkia, et al.
Bioimpacts : BI|June 29, 2026
Designing a novel therapeutic candidate vaccine for HPV16 using immunoinformatics approach: Targeting E6 and E7 epitopes with TLR4 agonist integrationZahra Samadi Moghaddam, Maryam Mashhadi Abolghasem Shirazi, Rosa Jahangiri, et al.
Future Oncology (London, England)|November 25, 2021
Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic virusesNasser Hashemi Goradel, Arezoo Alizadeh, Shahnaz Hosseinzadeh, et al.
Pageof 4